VBI Vaccines and Brii Biosciences expand Hepatitis B partnership to address prevention and treatment

VBI Vaccines recently announced the expansion of its hepatitis B (HBV) partnership with Brii Biosciences. This is a step towards combatting HBV by making improvements in preventing and treating patients with HBV. 

Adam Buckley, VBI's Senior Vice President, Business Development, is a member of the OBIO® Board of Directors.